Cabazitaxel in Relapsed and Metastatic NSCLC

计划入组 46 人 · 首次发布于 2013 年 5 月 13 日

Universal Cancer Peptide-based Vaccination in Metastatic NSCLC

计划入组 82 人 · 首次发布于 2016 年 6 月 29 日

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC

计划入组 30 人 · 首次发布于 2026 年 3 月 24 日

Multiple HLA-A2402 restricted epitope peptide vaccine (University of Tokyo/OncoTherapy Science)

squamous NSCLC vaccine

NSCLC (Antibody Therapeutics)

Nuvalent

United States

Arvinas

United States

Cardiff Oncology

United States

Less Restrictive Trial Criteria May Improve Outcomes in Metastatic NSCLC

Thoracic Radiotherapy Plus EGFR-TKI Improves Outcomes in EGFR-Mutated NSCLC

Novocure's Optune Lua Receives FDA Approval for Metastatic Non-Small Cell Lung Cancer